Comment
doi: 10.1200/JCO.2014.57.7379.
Epub 2014 Sep 2.
Reply to F. Tomao et al
Affiliations
- PMID: 25185088
- DOI: 10.1200/JCO.2014.57.7379
Item in Clipboard
Comment
Reply to F. Tomao et al
J Clin Oncol.
.
No abstract available
Comment on
-
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24637997 Clinical Trial.
-
Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial.J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.6231. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185105 No abstract available.
Similar articles
-
Emerging role for bevacizumab in combination with chemotherapy for patients with platinum-resistant ovarian cancer.J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24637996 No abstract available.
-
Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial.J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.6231. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185105 No abstract available.
-
Discussion: session 1.Future Oncol. 2013 Dec;9(12 Suppl):25-7. doi: 10.2217/fon.13.201. Future Oncol. 2013. PMID: 24195527 No abstract available.
-
[Standard of chemotherapy in ovarian cancer].Chirurg. 1994 Jan;65(1):18-22. Chirurg. 1994. PMID: 8149794 Review. German. No abstract available.
-
Chemotherapy of ovarian cancer.Semin Oncol. 1991 Jun;18(3):222-32. Semin Oncol. 1991. PMID: 2042062 Review. No abstract available.
Cited by
-
Bevacizumab in ovarian cancer: A critical review of phase III studies.Oncotarget. 2017 Feb 14;8(7):12389-12405. doi: 10.18632/oncotarget.13310. Oncotarget. 2017. PMID: 27852039 Free PMC article. Review.
-
Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer.Transl Cancer Res. 2020 Apr;9(4):2157-2160. doi: 10.21037/tcr.2020.02.75. Transl Cancer Res. 2020. PMID: 35117573 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
